注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Northwest Biotherapeutics Inc是一家生物技术公司。该公司专注于开发针对癌症的个性化免疫疗法。它开发的一种平台技术DCVax使用激活的树突状细胞来调动患者自身的免疫系统来攻击他们的癌症。该公司的产品线包括DCVax-L和DCVax-Direct。DCVax-L旨在治疗可通过手术切除肿瘤的实体瘤癌症。它已经完成了一项针对多形性脑癌(GBM)的DCVax-L的331名患者国际III期试验。DCVax-Direct旨在治疗无法手术的实体瘤。一项40名患者的I期试验已经完成,包括对十多种癌症的多种治疗。其全资子公司包括Flaskworks、Aracaris Ltd、Aracaris Capital, Ltd、Northwest Biotherapeutics B.V.和NW Bio GmbH。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Linda F. Powers | 65 | 2007 | Chairperson, CEO, President, CFO & Chief Accounting Officer |
Alton L. Boynton | 76 | 1998 | Founder, Chief Scientific Officer, Secretary & Director |
J. Cofer Black | 74 | 2016 | Independent Director |
Jerome Galon | - | - | Member of Scientific Advisory Board |
Samir N. Khleif | 60 | - | Member of Scientific Advisory Board |
Martin Cheever | 80 | - | Member of the Scientific Advisory Board |
John F. Smyth | - | - | Member of Scientific Advisory Board |
Henry Brem | 71 | 2005 | Member of Clinical Advisory Board |
Darell D. Bigner | - | 2005 | Member of Clinical Advisory Board |
Steven S. Brem | - | 2005 | Member of Clinical Advisory Board |
Tom Mikkelsen | - | 2005 | Member of Clinical Advisory Board |
Linda M. Liau | 56 | 2005 | Member of Scientific Advisory Board |
Navid Malik | 55 | 2012 | Independent Director |
Pat Sarma | 79 | 2024 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核